Daewon Co., Ltd. (KOSDAQ:007680)
4,515.00
+35.00 (0.78%)
At close: Apr 24, 2026
Daewon Revenue
In the year 2025, Daewon had annual revenue of 112.12B KRW, down -59.55%. Daewon had revenue of 28.49B in the quarter ending December 31, 2025, a decrease of -52.30%.
Revenue
112.12B
Revenue Growth
-59.55%
P/S Ratio
0.54
Revenue / Employee
1.01B
Employees
111
Market Cap
60.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 112.12B | -165.06B | -59.55% |
| Dec 31, 2024 | 277.18B | -158.91B | -36.44% |
| Dec 31, 2023 | 436.09B | 77.78B | 21.71% |
| Dec 31, 2022 | 358.31B | 69.02B | 23.86% |
| Dec 31, 2021 | 289.30B | 89.08B | 44.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cherrybro co.,Ltd | 405.44B |
| JMT Co.,Ltd. | 200.22B |
| Kyung Nam Pharm | 56.18B |
| Elcomtec | 46.29B |
| Green Lifescience | 40.34B |
| Sandoll | 19.97B |
| Satoshi Holdings | 18.90B |
| Aligned Genetics | 16.02B |